Abstract: The present invention relates to an amorphous form and its process for the preparation of [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-l-yl]oxolan-2-yl] methyl 2-methylpropanoate of Formula I.
Soft Copy Attached in Pdf
| # | Name | Date |
|---|---|---|
| 1 | 202141011266-Form 2(Title Page)_Provisional_17-03-2021.pdf | 2021-03-17 |
| 2 | 202141011266-Form 1_As Filed_17-03-2021.pdf | 2021-03-17 |
| 3 | 202141011266-Drawings_As Filed_17-03-2021.pdf | 2021-03-17 |
| 4 | 202141011266-Description Provisional_As Filed_17-03-2021.pdf | 2021-03-17 |
| 5 | 202141011266-Correspondence_As Filed_17-03-2021.pdf | 2021-03-17 |
| 6 | 202141011266-Form5_Complete After Provisional_14-03-2022.pdf | 2022-03-14 |
| 7 | 202141011266-Form3_Complete After Provisional_14-03-2022.pdf | 2022-03-14 |
| 8 | 202141011266-Form2 Title Page_Complete_14-03-2022.pdf | 2022-03-14 |
| 9 | 202141011266-Drawing_Complete After Provisional_14-03-2022.pdf | 2022-03-14 |
| 10 | 202141011266-Description Complete_Complete After Provisional_14-03-2022.pdf | 2022-03-14 |
| 11 | 202141011266-Correspondence_Complete After Provisional_14-03-2022.pdf | 2022-03-14 |
| 12 | 202141011266-Claims_Complete After Provisional_14-03-2022.pdf | 2022-03-14 |
| 13 | 202141011266-Abstract_Complete After Provisional_14-03-2022.pdf | 2022-03-14 |
| 14 | 202141011266-FORM 18 [11-03-2025(online)].pdf | 2025-03-11 |